Quick Answer
Beta Bionics, Inc. reported Gross Profit of $55.54 million for the year ending 2025.
- Beta Bionics, Inc. showed an increase of +54.8% in Gross Profit from 2024 to 2025.
- This data is from Beta Bionics, Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: $7.20 million | Q2 2024: $8.08 million | Q3 2024: $8.91 million | Q1 2025: $8.97 million | Q2 2025: $12.50 million | Q3 2025: $15.12 million.
- Over the full 3 years of available data (2023 to 2025), Beta Bionics, Inc.'s Gross Profit has grown by 780.4%.
- Historical annual values: Fiscal year 2025: $55.54 million | Fiscal year 2024: $35.89 million | Fiscal year 2023: $6.31 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: